Ligand Pharmaceuticals (United States)
In research, Ligand Pharmaceuticals (United States) stands highest in Life Sciences (#5,509 of 14,347 worldwide), Medicine (#12,396 of 17,978 worldwide) and Biochemistry, Genetics and Molecular Biology (#5,504 of 7,814 worldwide), over all time.
- World rank, all time
- #13,513 of 42,892
- Rank in United States
- #2,964 of 8,685
- Research works
- 411 ▲ 7% vs 2013–17
- Citations
- 22k 53.5 per fractional work
- Top-10% rate
- 13.0% record average 16.5%
- Open access
- 42% world 28%
What is Ligand Pharmaceuticals (United States) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #5,509 of 14,347 | 24.3% | 229 | |
| MedicineField | #12,396 of 17,978 | 27.3% | 139 | |
| Biochemistry, Genetics and Molecular BiologyField | #5,504 of 7,814 | 24.3% | 181 | |
| Health SciencesDomain | #15,547 of 20,462 | 27.2% | 141 |
Each strip is that field’s whole ranked pool, with the notch where Ligand Pharmaceuticals (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.0×. Every wedge is a field page.
Who are the top researchers at Ligand Pharmaceuticals (United States)?
Ranked on the composite score, Todd K. Jones, Marcus F. Boehm and William W. Lamph lead among researchers whose main affiliation is Ligand Pharmaceuticals (United States).
- 1 Todd K. Jones United States · #474,459 worldwide 157 citations · 16 works
- 2 Marcus F. Boehm United States · #522,120 worldwide 83 citations · 19 works
- 3 William W. Lamph United States · #606,448 worldwide 121 citations · 16 works
- 4 Alex M. Nadzan United States · #788,294 worldwide 31 citations · 19 works
- 5 Richard A. Heyman United States · #932,911 worldwide 77 citations · 19 works
Which keywords describe research at Ligand Pharmaceuticals (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Nuclear Receptors, Transcriptional Regulation, Breast Cancer, Signaling, Estrogen, Receptor, G Protein-Coupled Receptor and Glucocorticoids.
- Cytotoxicity
- Heterocyclic Compounds
- Synthesis
- Lipid Peroxidation
- Cancer Prevention
- Cardiovascular Risk
- Antioxidants
- Hormone Therapy
- Drug Discovery
- Diabetes
- Pharmacology
- Metabolic Syndrome
- Oxidative Stress
- Cancer
- Acute Promyelocytic Leukemia
- Inflammation
- Glucocorticoids
- Receptor
- Signaling
- Transcriptional Regulation
- Nuclear Receptors
- Breast Cancer
- Estrogen
- G Protein-Coupled Receptor
- Tamoxifen
- Gene Expression Regulation
- Retinoic Acid
- Reactive Oxygen Species
- Anticancer Agents
- Cell Signaling
- Biomarkers
- Apoptosis
- Antimicrobial Activity
- Atherosclerosis
- Metabolism
- Medicinal Chemistry
- Carotenoids
- Vitamin E
- Tumor Microenvironment
- Toxicology
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Nuclear Receptors115▲ 153×5 topics
- Transcriptional Regulation75▲ 73×6 topics
- Breast Cancer67▲ 58×7 topics
- Signaling65▲ 139×4 topics
- Estrogen64▲ 206×2 topics
- Receptor63▲ 213×2 topics
- G Protein-Coupled Receptor62▲ 229×2 topics
- Glucocorticoids62▲ 268×1 topic
- Tamoxifen62▲ 268×1 topic
- Inflammation56▲ 5.8×39 topics
- Gene Expression Regulation42▲ 89×2 topics
- Acute Promyelocytic Leukemia42▲ 342×1 topic
- Retinoic Acid42▲ 342×1 topic
- Cancer32▲ 5.6×23 topics
- Reactive Oxygen Species27▲ 13×10 topics
- Oxidative Stress25▲ 3.3×26 topics
- Anticancer Agents21▲ 20×6 topics
- Metabolic Syndrome20▲ 5.5×11 topics
- Cell Signaling18▲ 13×8 topics
- Pharmacology18▲ 14×7 topics
- Biomarkers17▲ 6.8×5 topics
- Diabetes17▲ 8.1×7 topics
- Apoptosis16▲ 9.7×8 topics
- Drug Discovery15▲ 9.4×8 topics
- Antimicrobial Activity15▲ 20×5 topics
- Hormone Therapy14▲ 33×3 topics
- Atherosclerosis14▲ 9.5×5 topics
- Antioxidants14▲ 8.1×4 topics
- Metabolism14▲ 5.1×12 topics
- Cardiovascular Risk14▲ 9.4×6 topics
- Medicinal Chemistry13▲ 8.2×7 topics
- Cancer Prevention12▲ 12×2 topics
- Carotenoids12▲ 75×1 topic
- Lipid Peroxidation12▲ 41×2 topics
- Vitamin E12▲ 75×1 topic
- Synthesis12▲ 5.0×14 topics
- Tumor Microenvironment12▲ 8.1×6 topics
- Heterocyclic Compounds11▲ 17×5 topics
- Toxicology10▲ 12×4 topics
- Cytotoxicity10▲ 18×5 topics
Which research topics does Ligand Pharmaceuticals (United States) publish most on?
By volume in 2022–2025: Acute Myeloid Leukemia Research, Ovarian cancer diagnosis and treatment, Testicular diseases and treatments and Estrogen and related hormone effects.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Acute Myeloid Leukemia Research Hematology 0 works
- 2 Ovarian cancer diagnosis and treatment Reproductive Medicine 0 works
- 3 Testicular diseases and treatments Surgery 0 works
- 4 Estrogen and related hormone effects Genetics 0 works
- 5 Protein Degradation and Inhibitors Molecular Biology 0 works
- 6 Retinal Development and Disorders Molecular Biology 0 works
- 7 Hematopoietic Stem Cell Transplantation Hematology 0 works
- 8 Genetic Syndromes and Imprinting Genetics 0 works
- 9 Amino Acid Enzymes and Metabolism Biochemistry 0 works
- 10 Retinal Diseases and Treatments Ophthalmology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ligand Pharmaceuticals (United States)'s research output changed?
Output in 2018–2022 was 7% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Diego
- University of California San Diego
- San Diego State University
- Scripps Research Institute
- University of San Diego
- University of California San Diego Medical Center
- General Atomics (United States)
- Scripps Health
- Naval Medical Center San Diego
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.